Skip to main content
NCBI home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 1999 Jun 22;13(4):151–157. doi: 10.1002/(SICI)1098-2825(1999)13:4<151::AID-JCLA3>3.0.CO;2-A

Measurement of total and diffusible serum fluoride

Alfredo Rigalli 1, Rosa Alloatti 1, Rodolfo C Puche 1,✉
PMCID: PMC6807860  PMID: 10414594

Abstract

This article describes a technique for the measurement of total and diffusible F content of serum, at clinical significant concentrations of F (1–10 μM). The proposed procedure avoids the interference of unknown serum components with the ion‐specific electrode. Sample F is concentrated fivefold through distillation of hydrofluoric acid (Taves' method). Ionic fluoride is presented to the electrode in a simple solution at concentrations within the linear response of the electrode. Average recoveries of F from serum or its ultrafiltrate were 96 ± 7% (21%) and 97 ± 12% (53%) (mean ± SEM [CV]), respectively. With four replicates of each sample, the technique produce within‐run standard deviations of 0.6 μM and 2.2 μM at 1 and 10 μM F, respectively. Total precision assessment gave standard deviations of 0.6 μM and 2.6 μM at 1 and 10 μM F, respectively. The fasting serum F levels of normal climacteric women, 45 to 65 years, showed an asymmetric distribution. The data obtained started at the detection limit of the technique (0.1 mM). The 75 percentile was 1.85 μM for total and 0.5 μM for diffusible F. In patients (n = 25) treated with NaF (30 mg F/day) the fasting levels of total serum F (4.5 ± 1.7 μM) did not differ from those of diffusible F (4.2 ± 1.5 μM). In patients (n = 50) treated with sodium monofluorophosphate (15 mg F/day) the fasting levels of total and diffusible serum F were 6.5 ± 1.7 μM and 0.5 ± 0.03 μM, respectively.In conclusion, this paper establishes the presence of two fractions of serum fluorine: diffusible and nondiffusible (or protein bound) and describes a technique for their clinical estimation. In untreated subjects and in patients receiving NaF, the former fraction contains ionic fluoride. In patients treated with MFP, diffusible serum fluorine is composed by ionic fluoride and low molecular weight, peptide‐bound, acid‐labile fluorine. J. Clin. Lab. Anal. 13:151–157, 1999. © 1999 Wiley‐Liss, Inc.

Keywords: serum fluoride‐protein‐bound, osteoporosis, bone mass

REFERENCES

  • 1. Taves DR. New approach to the treatment of bone disease with fluoride. Fed Proc 1970;29:1185–87. Medline [PubMed] [Google Scholar]
  • 2. Taves DR. Electrophoretic mobility of serum fluoride. Nature 1968;220:582–583. Medline [DOI] [PubMed] [Google Scholar]
  • 3. Tave DR. Evidence that there are two forms of fluoride in human serum. Nature 1968;217:1050–1051. [DOI] [PubMed] [Google Scholar]
  • 4. Singer L, Armstrong WD. Total fluoride content of human serum. Arch Oral Biol 1969;14:1343–1347. Medline [DOI] [PubMed] [Google Scholar]
  • 5. Venkateswarlu P, Singer L, Armstrong WD. Determination of diffusible (plus ionizable) fluoride in biological fluids. Anal Biochem 1971;42:350–359. Medline [DOI] [PubMed] [Google Scholar]
  • 6. Lau KHW, Farley JR, Freeman TK, Baylink DJ. A proposed mechanism of the mitogenic action of fluoride on bone cells: inhibition of the activity of an osteoblastic acid phosphatase. Metabolism 1989;38:858‐868.Medline [DOI] [PubMed] [Google Scholar]
  • 7. Rigalli A, Esteban L, Pera L, Puche RC. Binding of monofluorophosphate to α2‐macroglobulin and C3. Calcif Tissue Int 1997;60:86–89. Medline [DOI] [PubMed] [Google Scholar]
  • 8. Rigalli A, Cabrerizo MA, Beinlich AD, Puche RC. Gastric and intestinal absorption of monofluorophosphate and fluoride in the rat. Fortschr Arzneimittelforsch 1994;44:651–655. [PubMed] [Google Scholar]
  • 9. Rigalli A, Morosano M, Puche RC. Bioavailability of fluoride administered as sodium fluoride or sodium monofluorophosphate to human volunteers. Fortschr Arzneimittelforsch 1996;46:531–533. [PubMed] [Google Scholar]
  • 10. Orion Research Inc. Cambridge, Mass . Form IM94,96/2840.
  • 11. Taves DR. Determination of submicromolar concentrations of fluoride in biological samples. Talanta 1968;15:1015–1023. [DOI] [PubMed] [Google Scholar]
  • 12. The United States Pharmacopeia . The National Formulary, United Sates Pharmacopeial Convention Inc., Rockville, MD; 1990. [Google Scholar]
  • 13. Hallsworth AS, Weatherell JA, Deutsch D. Determination of subnanogram amounts of fluoride with the fluoride electrode. Anal Chem 1976;48:1660–64. [DOI] [PubMed] [Google Scholar]
  • 14. NCCLS Tentative Guideline EP5‐T. User evaluation of precision performance of clinical chemistry devices. Villanova, PA: National Committee for Clinical Laboratory Standards ; 1984.
  • 15. Clark LC, Thompson HL. Determination of creatinine. Anal Chem 1949;17:6–10. [Google Scholar]
  • 16. Snedecor GW, Cochran WG. Statistical Methods. Ames: Iowa State University Press, 1967. [Google Scholar]
  • 17. Guy WS. Inorganic and organic fluoride in human blood In: Johansen T, Taves D, Olsen B, editors. Continuing evaluation of the use of fluorides. AAAS Selected Symposium Series 11:125–147; Boulder, CO: Westview; 1967. [Google Scholar]
  • 18. Guy WS, Taves DR, Brey WS Jr. Organic fluorocompounds human serum; prevalence and characterization In: Filler W, editor. Biochemistry involving carbon‐fluorine bonds. Am Chem Soc Symp Ser 1977;28:117–134. [Google Scholar]
  • 19. Chen PS Jr, Smith FA, Gardner DE, O'Brien JA, Hodge HC. Renal clearance of fluoride. Proc Soc Exp Biol Med 1956;92:879–883. [DOI] [PubMed] [Google Scholar]
  • 20. Ekstrand J. A micromethod for the determination of fluoride in blood serum and saliva. Calcif Tissue Res 1977;23:225–228. Medline [DOI] [PubMed] [Google Scholar]
  • 21. Cox FH, Dirks BO. The determination of fluoride in blood serum. Caries Res 1968;2:69–78. Medline [DOI] [PubMed] [Google Scholar]
  • 22. Meys E, Terreaux‐Duvert F, Beaume‐Six T, Dureau G, Meunier PJ. Bone loss after cardiac transplantatiion: effects of calcium, calcidiol and monofluorophosphate. Osteoporos Int 1993;3:322–329. Medline [DOI] [PubMed] [Google Scholar]
  • 23. Battmann A, Resch H, Libanati CR, et al. Serum fluoride and serum osteocalcin levels in response to a novel sustained‐release monofluorophosphate preparation: comparison with plain monofluorophosphate. Osteoporos Int 1997;7:48–51. Medline [DOI] [PubMed] [Google Scholar]
  • 24. Mamelle N, Dusan R, Martin JL, et al. Risk benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet 1988;13:361–365. [DOI] [PubMed] [Google Scholar]
  • 25. Fry BW, Taves DR. Serum fluoride analysis with the fluoride electrode. J Lab Clin Med 1970;75:1020–1025. Medline [PubMed] [Google Scholar]
  • 26. Fuchs C, Dorn D, Fuchs CA, et al. Fluoride determination in serum by ion selective electrode: a simplified method for the clinical laboratory. Clin Chim Acta 1975;60:157–167. Medline [DOI] [PubMed] [Google Scholar]
  • 27. Whitford GM, Pashley DJ, Stringer GI. Fluoride renal clearance: a pH dependent event. Am J Physiol 1976;230:527–532. Medline [DOI] [PubMed] [Google Scholar]
  • 28. Waterhouse C, Taves D, Munzer A. Serum inorganic fluoride: changes related to previous fluoride intake, renal function and bone resorption. Clin Sci 1980;58:145–152. Medline [DOI] [PubMed] [Google Scholar]
  • 29. Ekstrand J. Relationship between fluoride and the drinking water and the serum fluoride concentration in man. Caries Res 1978;12:123–127. Medline [DOI] [PubMed] [Google Scholar]
  • 30. Cowell DC, Taylor WH. Diffusible fluoride: a study of its physiological variation in man. Ann Clin Biochem 1981;18:76–83l. Medline [DOI] [PubMed] [Google Scholar]
  • 31. Husdan H, Vogl R, Oreopoulos D, Gryfe C, Rapport A. Serum diffusible fluoride: normal range and relationship to age and sex. Clin Chem 1976;22:1884–1888. Medline [PubMed] [Google Scholar]
  • 32. Singer L, Orphaug RH. Concentrations of diffusible, total and bound fluoride in serum. Clin Chem 1979;25:523–25. Medline [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES